Federal health officials say that the manufacturer of a medical instrument at the center of a recent “superbug” outbreak in Los Angeles did not receive federal clearance to sell the device.
The Food and Drug Administration has confirmed that Olympus Corp. did not seek FDA clearance for the latest version of its specialized endoscope, which it began selling in 2010. FDA clearance is required for all substantive updates to medical device sold in the U.S.
Despite the lack of clearance, the FDA said doctors should continue using the device because it’s not clear that a federal review would have prevented the recent infections.
Olympus has now submitted an application for the device that is currently under FDA review
Was this article valuable?
Here are more articles you may enjoy.
North Carolina Becomes First State to Pass Outright Ban on Litigation Financing 
Bayer’s Supreme Court Win in Roundup Case No ‘Silver Bullet’ 
‘Ghost Broker’ Who Procured 1,120 Policies Through Fraud Arrested 
Florida’s Unemployment Rate Is Surging Even as High-Profile Companies Move In 
